Logo
User Name

Elnur Smajić

Društvene mreže:

I. V. Van Gelder, M. Rienstra, K. Bunting, Rubén Casado-Arroyo, V. Caso, Harry J G M Crijns, T. D. De Potter, Jeremy Dwight, Luigina Guasti et al.

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

<p style="text-align: justify;"><span style="font-size: 12pt; font-family: arial, helvetica, sans-serif;">The modernization of health care as a whole in the era of automation and the increasingly frequent use of ICT is noticeably reflected in the change in the structure of the education system of health workers, the program content of personnel education, the duration of education and training of personnel, mass at all levels of education, and more. All this resulted in significant changes within the entire health and education system. Due to the multitude of technical and technological achievements, the area of ​​application of new technique and technology in the process of education and professional development could not remain outside the influence. By introducing this new factor (technological-technical) into education, it was learned that systematic changes will be needed, i.e., not only changes within the teaching forms and methods but also changes in the function of the manager in the health organization.&nbsp;</span></p> <p>&nbsp;</p> <p>&nbsp;</p>

S. Halvorsen, J. Mehilli, S. Cassese, T. S. Hall, M. Abdelhamid, E. Barbato, S. D. De Hert, Ingrid de Laval, T. Geisler et al.

D. Mršić, J. Smajlović, D. Lončar, Sevleta Avdić, M. Avdagic, Elnur Smajić, Mugdim Bajrić, Alan Jahić

Introduction: The most common cause of myocardial ischemia is atherosclerotic epicardial coronary artery disease, present in 90% of patients. Risk factors positively correlate with the onset, development and subsequent complications of atherosclerotic disease. Aim: Determine the percentage frequency of classic risk factors for coronary disease in patients with non-ST segment elevation myocardial infarction (NSTEMI), with regard to gender. Methods: A retrospective study was conducted on 600 respondents, treated for NSTEMI at the Clinic for Internal Medicine of the University Clinical Center (UKC) Tuzla, in the period from June 2016 to December 2019. Results: Overall, smoking was the leading risk factor (65%), followed by hypertension (58%), hyperlipoproteinemia (39%), overweight (33%), positive family burden (30%) and diabetes mellitus (19%). In male patients, the leading risk factor was smoking, rating at 74%, while in female patients – it was hypertension at 67%. In younger groups of patients leading risk factors were smoking and a positive family burden. Conclusion: With adequate prevention and treatment measures, a significant reduction in the prevalence of the cardiovascular disease can be achieved, since the risk factors for its development have long been known. Quitting smoking is one of the most effective secondary prevention measure since it reduces the reinfarction risk rate by 50%. Knowledge of coronary risks, as well as success in reducing them, can greatly contribute to patients’ overall sense of contentment and significantly raise their self-confidence.

G. Hindricks, Tatjana Potpara, Nikolaos Dagres, Elena Arbelo, Jeroen J. Bax, Carina Blomström-Lundqvist, G. Boriani, Manuel Castellá, Gheorghe-Andrei Dan et al.

E. Hodžić, Ehlimana Pecar, A. Džubur, Elnur Smajić, Zorica Hondo, D. Delić, Edhem Rustempašić

Introduction: Perindopril is a tissue-specific ACE inhibitor with 24 hours long blood pressure-lowering effect, which protects blood vessels and decreases the variability of blood pressure. Aim: The aim of our study was to investigate the effectiveness and safety of perindopril in newly diagnosed or previously treated but uncontrolled adult hypertensive patients. Methods: This prospective cohort study included primary care patients with essential hypertension. Primary study outcomes were decreasing arterial blood pressure to normal levels (<140/90 mmHg), reducing systolic arterial blood pressure for 10 mmHg or more and reducing diastolic arterial blood pressure for 5 mmHg or more. Safety was evaluated by type and frequency of adverse events. Results: In the great majority of the study patients (more than 96%) perindopril was effective as monotherapy, achieving a significant reduction in both systolic and diastolic blood pressure, and in three-quarters of the study patients it normalized both systolic and diastolic blood pressure. The effectiveness of perindopril was shown in both patients with previously and newly diagnosed hypertension, adverse events were mild and rare, even hyperkalemia was encountered less often than before the onset of the therapy with perindopril. Conclusions: Our study confirmed excellent effectiveness of perindopril in the treatment of essential hypertension and its remarkable safety. When used as monotherapy of hypertension, perindopril’s doses should be carefully titrated until the achievement of full effect, which in some patients should be awaited for at least 6 months from onset of the therapy.

...
...
...

Pretplatite se na novosti o BH Akademskom Imeniku

Ova stranica koristi kolačiće da bi vam pružila najbolje iskustvo

Saznaj više